Answers are grounded in this paper and cite their sources.
CYCLONAMINE (diethylammonium 1,4-dihydroxy-3-benzenesulphonate; Dicynone)4 is a synthetic haemostatic the action of which results from an increase in vascular resistance associated with reduced bleeding time. Raby and Coupier (1965), in a series of cases with increased capillary fragility, showed a favourable increase in vascular resistance after the intravenous 1inJection of 250 mg. cyclonamine. Canal (1964), in a double-blind trial, 'demonstrated it mean reductiodn in bleeding time of 33 8 per cent. (placebo 8-1 per cent.) with oral cyclonamine, and in a second group of patients a mean reduction of 32-9 per cent. (placebo 4-5 per cent.) one hour after the intramuscular injection of 500 mg. cyclonamine. Borel (1962) was impressed with the drug in general" surgical use, and Volet, Bonhote, Skouvaklis, and Locher (1963) demonstrated a reduction in blood loss in gynaecological surgery.
No takes yet. Share an insight, caveat, or question.
Hypher et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: